{"meshTags":["Adenocarcinoma","Drug Administration Schedule","Drug Resistance, Neoplasm","Female","Humans","Lung Neoplasms","Middle Aged","Mutation","Protein Kinase Inhibitors","Quinazolines","Receptor, Epidermal Growth Factor"],"meshMinor":["Adenocarcinoma","Drug Administration Schedule","Drug Resistance, Neoplasm","Female","Humans","Lung Neoplasms","Middle Aged","Mutation","Protein Kinase Inhibitors","Quinazolines","Receptor, Epidermal Growth Factor"],"genes":["EGFR"],"publicationTypes":["Case Reports","Comment","Letter"],"title":"Acquired gefitinib-resistant mutation of EGFR in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R.","pubmedId":"16173832"}